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Abstract
In obesity, there is an increase in reactive oxygen species (ROS) within adipose tissue caused by increases in inflammation
and overnutrition. Hormone sensitive lipase (HSL) is part of the canonical lipolytic pathway and critical for complete
lipolysis. This study hypothesizes that ROS is a signal that integrates regulation of lipolysis by targeting HSL. Experiments
were performed with human differentiated adipocytes from the subcutaneous depot. Antioxidants were employed as a tool
to decrease ROS, and it was found that scavenging ROS with diphenyliodonium, N-acetyl cysteine, or resveratrol decreased
lipolysis in adipocytes. HSL phosphorylation of a key serine residue, Ser552, as well as translocation of this enzyme from the
cytosol to the lipid droplet upon lipolytic stimulation were both abrogated by scavenging ROS. The phosphorylation status
of other serine residues on HSL were not affected. These findings are significant because they document that ROS
contributes to the physiological regulation of lipolysis via an effect on translocation. Such regulation could be useful in
developing new obesity therapies.
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Introduction
HormoneSensitiveLipase(HSL)isakeyenzymeintheregulation
of lipid, the largest energy reserve in the body. Recently, there has
beenarenewedinterestinHSLasanattractivetherapeuticcandidate
forobesitybecauseofitscrucialroleinlipolysis.Thelipolyticpathway
hasbeendescribedforquitesometime;however,theregulationofthis
pathwayisnotaswelldefined.Inthisstudy,weexamineregulationof
lipolysisandspecificallyHSLmodulationbyreactiveoxygenspecies
(ROS), which are increased inobesity.
Reduced activity of HSL improves metabolic homeostasis. Mice
thatlackafunctionalcopyofthegeneencodingHSLareresistantto
both genetic and diet-induced obesity [1,2]. Additionally, human
studieshaverevealedthatcarryinganalleleassociatedwithdecreased
HSL hydrolytic activity is associated with an improved metabolic
phenotype.Specifically,womencarryingthisallelehavelowerbasal
andstimulatedinsulinsecretion,andmenwiththisallelehavelower
circulating non-esterified fatty acids (NEFAs) [3].
As the name suggests, HSL hydrolyzes esters of neutral lipids,
principallydiacylglyceride(DG),inamanneractivatedbyavarietyof
hormones that increase cAMP, including catecholamines, adreno-
corticotropichormone(ACTH)andglucagon[4].ProteinKinaseA
(PKA),activatedviaanincreaseincAMP,phosphorylatesratHSLon
three serine residues, Ser563, Ser659 and Ser660 [5]. These three
sites are conserved in human HSL, as Ser552, Ser649 and Ser650,
respectively[6].Invitro,phosphorylationofhumanHSLSer649and
Ser650 arethe major determinants of its hydrolytic activity[7].
Upon phosphorylation, HSL translocates to the lipid droplet to
participate in lipolysis. PKA phosphorylation induces a conforma-
tional change to expose hydrophobic groups on HSL, which
facilitates HSL binding to its substrate, lipid [8]. However, it is
unknown which of these three PKA-mediated serine residues is the
major determinant of translocation of HSL from the cytosol to the
lipid droplet upon lipolytic stimulation. This important layer of
regulation also regulates other lipid handling enzymes, including
Lipin 1and ACSL[9,10].
ROSisacandidatefortheregulationoflipolysis,becausethereisa
positivecorrelationbetweenbothROSandlipolysiswithobesity[11–
14]. In obesity, inflammation and overnutrition converge on an
increaseinROS.Recently,therehasbeenaparadigmshiftthatROS,
previously described as a trigger of programmed cell death and a
uselessby-productofcellularrespiration,isalsoasignalingmolecule
andcanbehelpfulratherthanexclusivelyharmful[15].Infact,ROS
hasbeenshowntobeametabolicsignalforglucose-stimulatedinsulin
secretion[16]. GiventheincreaseofROS inobesity andits roleasa
metabolic signal, we hypothesize that ROS is a modulator of
adipocyte lipolysis.
Results
ROS Production was Decreased by, Diphenyliodonium
(DPI), N-acetyl Cysteine (NAC) and Resveratrol
ROS levels are increased in obesity and decreased by ROS
scavengers.
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34904It can be a challenge to increase ROS levels modestly in cell
culture models, although scavenging with antioxidants is feasible.
Various reactive species have different half-lives and may act in
different compartments that are difficult to target in a cell culture
system. Also, a portion of ROS is scavenged by components of the
experimental media including pyruvate [17]. Thus, many
experimental designs use superphysiological ROS treatments,
which may not be physiologically relevant. For these reasons, our
studies used several antioxidants to decrease ROS levels in
cultured adipocytes. To validate the decrease in ROS levels in this
model, cells were incubated with established antioxidants [18–20],
at concentrations comparable to those used in the literature of
ROS-related research, and then ROS levels were assessed using
the ROS-sensitive intracellular fluorescent dye CM-H2-DCFDA.
Figure 1 shows that over 1.5 hours of measurement, ROS levels
decreased compared to control with each antioxidant, DPI, NAC
and resveratrol. 5 mM forskolin, used in this study to induce
lipolysis, had no effect on induction of ROS under control or
antioxidant conditions.
Scavenging ROS Decreased Lipolysis
We next assessed lipolysis by measuring glycerol release from
cells into the cell culture media. Figure 2A shows that in cultured
adipocytes, the antioxidant DPI decreased both basal and
forskolin-stimulated lipolysis compared to their respective controls.
These findings are in agreement with published literature using
freshly isolated rat adipocytes [21].
Next, we determined whether the effect of DPI on lipolysis was
specific for DPI or if other antioxidants also decreased lipolysis.
Figure 2B shows that the antioxidants, NAC and resveratrol also
inhibited stimulated lipolysis.
Scavenging ROS did not Alter cAMP, PKA and Perilipin
Taken together, the above data showed that scavenging ROS
inhibited lipolysis. To determine the mechanism, we investigated
the cAMP lipolytic pathway. cAMP is a common point of
regulation of lipolysis [22]. Upon lipolytic stimulation, cAMP
levels peak at 15 minutes [23]. Basal and forskolin-stimulated
cAMP levels were assessed at this time point and each was not
altered by DPI treatment compared to its respective control
(Figure 3A). Next, the activity of PKA, cAMP’s downstream
target, was assessed using an antibody against an epitope tag for
sites phosphorylated by PKA. The western blot in Figure 3B
shows no alteration of PKA activation under either basal or
forskolin-stimulated conditions in the presence of DPI compared
to control.
To confirm the lack of effect on PKA, we next measured the
phosphorylation state of individual proteins that PKA phosphor-
ylates. Perilipin, a lipid droplet coating protein, is hyperpho-
sphorylated upon lipolytic stimulation. Perilipin phosphorylation
facilitates HSL-mediated lipolysis by its interaction with lipid
droplet associated HSL [24]. This hyperphosphorylation decreases
the mobility of perilipin through an SDS page gel [25]. When a
10% polyacrylamide denaturing gel is run so that lower molecular
weight proteins run off the gel, the area around 57 kDa is
expanded so that decreased mobility of perilipin can be visualized.
In Figure 3C perilipin western blots show that although mobility
of perilipin after forskolin stimulation was decreased compared to
control, DPI did not alter perilipins gel migration pattern in the
presence or absence of forskolin stimulation.
Hormone sensitive lipase is another target of PKA, though it
can also be activated by other kinases [26]. A 4 hour treatment
with DPI diminished phosphorylation of HSL on Ser552
Figure 1. Antioxidant Structures and effect on ROS generation. (A) Each antioxidant scavenges ROS as a consequence of their chemical
structures. Each also has specific additional mechanisms: Diphenyliodonium (DP) inhibits NADPH oxidase, NAC increases cellular glutathione levels
and resveratrol is a sirtuin activator. (B) Human differentiated adipocytes were preincubated for half an hour in DMEM with 1% BSA and 5 mM of the
dye, CM-H2DCFDA. Cells were then washed and media were changed to HBSS. Compounds were added (10 mM DPI, 5 mM NAC or100 mM resveratrol)
in the absence or presence of 5 mM forskolin and fluorescent readings were taken for 1.5 hours at 37uC at wavelengths 485 nm excitation, 538 nm
emission. Data are expressed as the relative change of the final value minus the initial baseline reading. The panel shows normalized mean values 6
S.E.M. for three independent experiments; *p ,0.05 vs. basal control, # p,0.05 vs. forskolin control.
doi:10.1371/journal.pone.0034904.g001
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lation site [3].
Further studies were undertaken to determine how deficient
phosphorylation of HSL Ser552 decreased lipolysis in the presence
of DPI. We next assessed the time course of decrease in this site’s
phosphorylation in the presence of DPI under forskolin stimula-
tion. Phosphorylation of HSL Ser552 was prevented by DPI as
early as 15 minutes following compound exposure (our earliest
time point) and was maintained at 1 hour of treatment (Figure 4B
and C).
HSL Ser554 and Ser650 Phosphorylation was Unaltered
by DPI
Figure 5A summarizes potential mechanisms by which
phosphorylation of HSL Ser552 can occur. Studies of mouse
HSL reveal that when the neighboring HSL Ser565 (human
Ser554), is phosphorylated by AMPK, mouse Ser563 (human
Ser552) cannot be phosphorylated [27,28]. Western blots were
probed with anti-pHSL Ser554 antibody and revealed that
phosphorylation of this serine was not only unaltered in human
differentiated adipocytes by forskolin-induced lipolysis but addi-
tionally, the level of phosphorylation was unaltered by DPI
(Figure 5B). This rules out the possibility of AMPK phosphor-
ylation of HSL Ser552 being important in the context of this study.
Although cAMP levels and PKA substrate phosphorylation of
most proteins suggested that there was no alteration in activation
of this pathway in the presence of DPI, it is possible that HSL
phosphorylation by PKA was blocked even though PKA activity
was intact. HSL has been shown to associate with the lipid binding
protein aP2 [29] and perhaps this complex cannot be phosphor-
ylated by PKA in the presence of DPI. To address this possibility,
experiments were performed that probed western blots with anti-
HSL at Ser650, another site that PKA has been shown to
phosphorylate [30]. Figure 5B shows that HSL Ser650
phosphorylation was increased by forskolin as expected; however
this increase in phosphorylation with forskolin-stimulation was
unaltered in the presence of DPI. This result suggested that the
lack of HSL Ser552 phosphorylation might not be due to either
impairment of PKA activity or lack of access of PKA to HSL
because HSL Ser660 retained its ability to be phosphorylated
under lipolytic conditions in the presence of DPI.
DPI, NAC and Resveratrol Decreased Forskolin-mediated
Translocation of HSL from the Cytosol to the Lipid
Droplet
We next asked was how an alteration in phosphorylation of
HSL Ser552 might translate into a decrease in lipolysis?
Mutational analysis reveals that phosphorylation of Ser650 is a
major determinant of the hydrolytic activity of HSL, while
phosphorylation of Ser552 is not a major contributor [7].
Additionally, phosphorylation of traditional PKA sites (Ser552,
Ser649 and Ser650) induces a conformational change of HSL,
revealing hydrophobic groups, which may aid in the translocation
of this lipase to the lipid droplet [8]. Thus, we asked if our western
blot results i.e. a loss of phosphorylation of HSL Ser552 with
retained phosphorylation of HSL Ser650 correlated with a
decrease in translocation of HSL from the cytosol to the lipid
droplet. Fixed cells were examined by confocal microscopy after a
15 minute treatment with DPI. Figure 6A shows images
demonstrating that DPI decreased forskolin-stimulated transloca-
tion of HSL from the cytosol to the lipid droplet. Image analysis of
these data documented a 50% decrease in HSL translocation
(Fig 6B insert). To determine if this mechanism of lipolytic
inhibition was common to all antioxidants tested in these lipolysis
experiments, further translocation experiments were performed
with NAC and resveratrol treatments. Figures 7A and 7B and
8A and 8B illustrate and quantitate that NAC and resveratrol also
inhibited forskolin-stimulated translocation of HSL from the
cytosol to the lipid droplet. Taken together, these data suggest a
model in which HSL phosphorylation of Ser552 and translocation
to the lipid droplet are impaired by scavenging ROS.
Discussion
Lipolysis is Altered by Scavenging ROS
The exciting finding from these studies is documentation of
ROS as an important regulator of lipolysis. The implication of
these data is that: 1) ROS has a physiological role on lipolysis. 2)
lipolytic alterations that occur during obesity may be due to ROS.
With respect to the physiological role of ROS, the results of the
antioxidant studies suggest that ROS is a necessary component of
Figure 2. DPI, NAC and resveratrol decrease lipolysis. Human
differentiated adipocytes were treated with or without (A) 10 mM DPI,
(B) 5 mM NAC, or 100 mM resveratrol in the absence or presence of
5 mM forskolin for 4 hours in KRB containing 1% BSA and 0.5 mM oleate.
Media were collected and assayed for glycerol using an enzyme-linked
luciferase assay. Results for glycerol are normalized to the basal
condition and represented as fold increase. Average basal value was
16.7 6 1.7 nmols per million cells per hour, average forskolin-
stimulated value was 85.8 6 9.1 nmols per million cells per hour.
Values 6 S.E.M. for three independent experiments; * p ,0.05 vs. basal
control, # p,0.05 vs. forskolin control.
doi:10.1371/journal.pone.0034904.g002
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DPI, both basal and stimulated lipolysis are decreased. The
antioxidants NAC and resveratrol each also inhibited stimulated
lipolysis, suggesting that this was a bona fide antioxidant effect.
Experiments performed with freshly isolated rat adipocytes are in
agreement with the findings of this study [21].
Mechanistic Studies of Lipolysis
A number of mechanistic possibilities were assessed to
understand how ROS exerted an effect on lipolysis. The
lipolytic pathway was unaltered by DPI treatment as evidenced
by no alteration in cAMP, PKA substrate phosphorylation, or
perilipin phosphorylation. This suggested that DPI inhibited
lipolysis in an unconventional manner. One future direction is
to assess the cGMP non-canonical lipolytic pathway. Natriuretic
peptides (NPs), atrial (ANP) and brain NP stimulate lipolysis in
vitro [31,32] and in vivo [33,34] via a cGMP non-canonical
lipolytic pathway. Interestingly, HSL is phosphorylated in
response to ANP, although the specific serine residue(s) on
HSL that are phosphorylated are unknown. Of note, the
reactive oxygen species, NO also activates this pathway [35–37].
An examination of the DG lipase HSL led to some surprising
and novel modes of regulation of lipolysis. The phosphorylation
of the PKA site, HSL Ser552 was reduced in the presence of
DPI. Since this effect was seen as early as 15 min, it is likely
not due to an alteration in either translation or degradation of
HSL protein. However, phosphorylation of the PKA target site
HSL Ser650 did not change under these same experimental
conditions. AMPK is not implicated in the abrogation of HSL
Ser552 via increased phosphorylation of HSL Ser554, as
phosphorylation of the latter site was unchanged in the presence
of DPI. Of note, stimulation of lipolysis, which has been shown
to activate AMPK in 3T3-L1 cells [38] does not cause
phosphorylation of the AMPK site on HSL, Ser554 in human
differentiated adipocytes. Thus, PKA activity was intact in the
presence of DPI and phosphorylation of one PKA phosphor-
ylation site (Ser650) was intact.
These findings certainly do not rule out the regulation of other
lipases by antioxidants. Adipocyte triglyceride lipase (ATGL) is a
candidate for future studies since this lipase is the rate determining
enzyme of lipolysis [39] and b-adrenergic activation of ATGL is
required for maximal lipolysis [40].
Translocation of HSL
Work from the laboratory of Cecilia Holm et al revealed that
in vitro, HSL Ser649 and Ser650 are the major determinants of
hydrolytic activity, but not Ser552 [7]. This prompted us to ask
if perhaps in humans, Ser552 determines translocation instead
Figure 3. The lipolytic pathway is unaltered by DPI treatment. Human differentiated adipocytes were treated with or without 10 mM DPI in
the absence or presence of 5 mM forskolin. (A) 15 minutes in KRB with 1% BSA and 0.5 mM oleate. Cell lysates were collected and assayed for cAMP
using an ELISA-based assay. (B, C) Cells were treated under the same conditions for 4 hours. Individual proteins were analyzed by western blotting
with specific antibodies. Signals were visualized with an enhanced chemiluminescence substrate kit (Thermo Scientific, Rockford IL) as described in
materials and methods. Results for cAMP are normalized to the basal condition and represented as fold increase. Average basal value was 3.9 6 0.5
pmols per million cells, average forskolin-stimulated value was 68.9 6 13.9 pmols per million cells. Values 6 S.E.M. for three independent
experiments. Immunoblots shown are representative of those obtained in three separate experiments.
doi:10.1371/journal.pone.0034904.g003
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HSL Ser552 may be involved in translocation of HSL in
human adipocytes. The key experiment for this finding was the
decrease in translocation of HSL upon forskolin-stimulation in
the presence of DPI, a condition where HSL Ser552
phosphorylation was also abrogated and lipolysis was decreased.
In 3T3L1 cells, it has been shown that the HSL double mutant
of Ser659RAla/Ser660RAla (human Ser649 and Ser660) does
not translocate to the lipid droplet although single mutations of
each PKA site retain the ability to translocate [41].
These data suggest that the ability of the enzyme to be
localized near its substrate is an important layer of regulation.
To date, this is the first study implicating human HSL Ser552
as a key residue for lipolysis. Evidence in 3T3L1 cells suggests
that translocation precedes phosphorylation at HSL Ser563
(human HSL Ser552) [42]. Further experiments need to be
performed to determine the order of these two events in human
adipocytes.
This is also the first study to suggest that under some
conditions, such as altered ROS, two PKA-target phosphoryla-
tion sites (HSL Ser650 and Ser552) do not always have the
same pattern of phosphorylation. This could suggest that two
distinct kinases phosphorylate these two serine residues. Older
literature names glycogen synthase kinase 4 (GSK-4) (now
renamed to GSK-3ß) as a kinase that phosphorylates HSL at
Ser552 [26,43,44].
Figure 4. HSL phosphorylation was decreased by DPI treatment under lipolytic stimulation after 15 min, 1 hour and 4 hours. Human
differentiated adipocytes were treated with or without 10 mM DPI in the absence or presence of 5 mM forskolin for (A) 4 hours (B) 1 hour or (C) 15
min in KRB with 1% BSA and 0.5 mM oleate. Individual proteins were analyzed by western blotting with specific antibodies. Signals were visualized
with an enhanced chemiluminescence substrate kit (Thermo Scientific, Rockford IL) as described in materials and methods. Immunoblots shown are
representative of those obtained from three separate experiments.
doi:10.1371/journal.pone.0034904.g004
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34904Figure 5. Regulation of HSL by phosphorylation. As reviewed by Lampidonis et al [46]. (A) HSL can be phosphorylated by a number of kinases.
PKA is able to phosphorylate human HSL at Ser563, Ser649 and Ser650. ERK can phosphorylate HSL at Ser589. AMPK can phosphorylate HSL at
Ser554, which in some tissues reduces HSL phosphorylation at Ser552 by PKA and inhibits HSL activity. Phosphorylation at HSL Ser650 and Ser554 is
unaltered by DPI treatment. (B) Human differentiated adipocytes were treated with or without 10 mM DPI in the absence or presence of 5 mM
forskolin for 15 minutes in KRB with 1% BSA and 0.5 mM oleate. Individual proteins were analyzed by western blotting with specific antibodies.
Signals were visualized with an enhanced chemiluminescence substrate kit (Thermo Scientific, Rockford IL) as described in materials and methods.
Immunoblots shown are representative of those obtained from three separate experiments.
doi:10.1371/journal.pone.0034904.g005
Figure 6. DPI abrogated forskolin-induced HSL translocation from the cytosol to the lipid droplet. Human differentiated adipocytes
were grown and differentiated in 35 mm coated glass bottom dishes and then treated with or without 10 mM DPI in the absence or presence of 5 mM
forskolin for 15 min in KRB containing 1% BSA and 0.5 mM oleate. Cells were then fixed with paraformaldehyde and subsequently incubated with
anti-total HSL antibody (green), cells were also labeled with Lipotox red for lipid droplet detection (red), as described in the methods section. Cells
were imaged in these 35 mm dishes in an inverted microscope. Confocal pictures were taken (A) Images were analyzed using ImageJ software. (B)
The panel shows normalized mean values 6 S.E.M. for three independent experiments with at least 50 cells per condition per experiment; * p ,0.05
vs. basal, # p,0.05 vs. forskolin.
doi:10.1371/journal.pone.0034904.g006
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The testable model that evolves from these data is that ROS
is an important signal that promotes lipolysis, and we propose
that the mechanism by which this occurs is by altered
translocation of HSL from the cytosol to the lipid droplet.
This leads to the questions: 1) Under conditions of high ROS,
as in obesity, is the increase in lipolysis mediated by ROS? 2)
Could other lipolytic components and also lipid synthetic
enzymes be regulated in a similar manner by ROS, i.e.,
translocation? Lastly, this paper aims to instill a renewed
interest in HSL as a target of small molecule inhibitors and
activators as a means of modulating lipid turnover under
conditions of both excess and also reduced lipid storage.
Methods
Cell Culture
The differentiation of human primary preadipocytes into
adipocytes was carried out essentially as previously described
[45]. The Adipocyte Core of the Boston Nutrition Obesity
Research Center (BNORC) DK46200 provided the preadipo-
cytes. The cells were completely de-identified and were given to us
in a manner that does not link the samples to any private/
protected information. Originally, subcutaneous fat tissue was
obtained from subjects undergoing panniculectomy surgery by
BNORC. The preadipocyte population for five subjects cells were
then grown and pooled and the combined subjects cells were
Figure 7. NAC abrogated forskolin-induced HSL translocation from the cytosol to the lipid droplet. Human differentiated adipocytes
were treated as described in figure 6 except with or without 5 mM NAC for 15 minutes. Cell were then fixed with paraformaldehyde and
subsequently incubated with anti-total HSL antibody (green); cells were also labeled with Lipotox red for lipid droplet detection (red). Confocal
pictures were taken (A) and analyzed using image J software. (B) The panel shows normalized mean values 6 S.E.M. for three independent
experiments with at least 50 cells per condition per experiment; * p ,0.05 vs. basal, # p,0.05 vs. forskolin.
doi:10.1371/journal.pone.0034904.g007
Figure 8. Resveratrol abrogated forskolin-induced HSL translocation from the cytosol to the lipid droplet. Human differentiated
adipocytes were treated as described in figure 6 except with or without 100 mM resveratrol for 15 minutes. Cell were then fixed with
paraformaldehyde and subsequently incubated with anti-total HSL antibody (green), cells were also labeled with Lipotox red for lipid droplet
detection (red). Confocal pictures were taken (A) and analyzed using image J software. (B) The panel shows normalized mean values 6 S.E.M. for
three independent experiments with at least 50 cells per condition per experiment; * p ,0.05 vs. basal, # p,0.05 vs. forskolin.
doi:10.1371/journal.pone.0034904.g008
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Average subject was female age 41.665.4 with a BMI of 3667.6.
Once differentiated, these 5 subjects’ cells performed according to
established standards with respect to response to lipolytic agonists
and the rate of neutral lipid synthesis. All experiments were
performed with these cells between days 12–14 after differentia-
tion.
Antibodies
The following antibodies were purchased from Cell Signaling
Technology (Beverly, MA): polyclonal antibody against HSL,
polyclonal antibody against phosphorylated human HSL serine
residue 552 (rat 563), polyclonal antibody against phosphorylated
human HSL serine residue 554 (rat 565), polyclonal antibody
against phosphorylated human HSL serine residue 650 (rat 660),
monoclonal antibody against PKA substrates, and monoclonal
antibody against tubulin. Polyclonal antibody against perilipin A
was a kind gift from Dr. A. Greenberg (Tufts University),
previously described [43].
Lipolysis Assay
Cells were preincubated in Krebs Ringer Buffer (KRB)
(130 mM NaCl, 4.7 mM KCl, 2.5 MgSO4 mM, 3.3 mM CaCl2,
24.5 mM NaHCO3, 1 mM KH2PO4, 5 mM glucose, incubated
for 10–15 min with 5% CO2, 95% O2) for 30 minutes and then
switched to KRB with 0.5 mM oleate and 150 mM BSA in the
presence or in the absence of 5 mM forskolin for 4 hours. Glycerol
release was measured by using a luciferase based enzyme-linked
luminescent assay previously described [44]. All reagents and
enzymes were purchased from Roche (Indianapolis, IN). Antiox-
idants were validated to not cause an artifact in this assay by
adding each to a standard curve and observing that there was no
difference in each standard curves with or without antioxidant.
Immunoblotting
Proteins were separated in 10% SDS-polyacrylamide gels
(Biorad, Hercules CA) and transferred to a polyvinylidene fluoride
0.2 mm membrane (Biorad). Membranes were blocked with 5%
nonfat milk in TBS-T buffer (150 mM NaCl, 20 mM Tris-HCl,
pH 7.4, 0.1% Tween-20) for 1 hour. Membranes were then
probed overnight at 4uC with primary antibodies followed by 1
hour incubation with secondary antibody conjugated to horserad-
ish peroxidase. Protein bands were detected with an enhanced
chemiluminescence substrate kit (Thermo Scientific, Rockford IL)
using a FujiFilm LAS-4000 Luminescent Image Analyzer.
cAMP Measurement
cAMP was measured using a fluorescent assay kit (Molecular
Devices, Sunnyvale, CA) according to manufacturer’s instructions.
ROS Measurement
ROS measurements were performed with the ROS sensitive
dye CM-H2DCFDA, which cleaves to become DCF (Invitrogen
Molecular Probes, Eugene OR). Cells were grown and differen-
tiated in 12-well plates (2.3610ˆ5 cells per well). On the day of the
experiment, media was changed to DMEM with 1% BSA. CM-
H2DCFDA was added for a 30 minute preincubation at a final
concentration of 5 mM. Cells were then washed and media was
changed to Hank’s Balanced Salts (HBSS). Fluorescent readings
were taken on a plate reader (Tecan, Austria) every 30 seconds for
1.5 hours at 37uC at excitation 485, emission 538 nm. A
preliminary experiment was performed to establish conditions
and it was determined that BSA interferes with the assay and was
therefore not included during the 1.5 hours of measurement
although 0.1% is added during the loading of CM-H2DCFDA
into the cells.
Immunocytochemistry
Cells were grown and differentiated in 35 mm coated glass
bottom dishes (Greiner bio-one, Advanced glass bottom Germany)
and subsequently imaged in these plates in an inverted
microscope. At the commencement of the experiment, cells were
fixed for 20 minutes in 4% formaldehyde and then blocked and
concomitantly permeabilized for one hour in PBS with 0.3%
Triton X-100 and 5% goat serum at room temperature. Cells were
stained overnight at 4uC with the primary antibody, anti-HSL
(Cell Signaling, Beverly, MA) at a 1:200 dilution in PBS with 0.3%
Triton X-100 and 1% BSA, followed by a one hour incubation at
room temperature with Alexa Fluor 488 anti-rabbit secondary
antibody (Invitrogen, Eugene, OR) at a 1:400 dilution, while
concomitantly staining with Lipotox red stain (Invitrogen, Eugene,
OR) at a 1:1000 dilution to visualize lipid droplets and Hoescht
33342 (AnaSpec Inc, San Jose, CA) at a 1:1000 dilution to
visualize nuclei. The solution was then replaced with 100 mlo f
SlowFade Gold antifade reagent (Invitrogen, Carlsbad, CA) and
cells were examined by confocal fluorescent microscopy using a
Zeiss LSM 710-Live Duo scan microscope. (Zeiss, Thornwood,
NY).
Confocal Image Analysis
Data were analyzed using ImageJ software from the National
Institute of Health (NIH) (Bethesda, MD) and can be found at
http://imagej.nih.gov/ij/. Figure S1 is the macro that was
generated and run in ImageJ to analyze HSL translocation from
the cytosol to lipid droplets. Briefly, the goal was to measure the
pixel intensity around each lipid droplet and also measure the
pixel intensity within the cytosol. This ratio of average pixel
intensity around the lipid droplet over average pixel intensity of
the cytosol was termed the ‘translocation to the lipid droplet’ and
was used as an index to compare experimental conditions to
control.
Data Analysis and Statistics
Student’s paired two-tailed t test was used to evaluate statistical
significance of results. Values of p , 0.05 were considered to be
significant differences.
Supporting Information
Figure S1 Macro to analyze HSL translocation with
Image J software. For the pixel intensity around the lipid
droplet, the confocal picture of the lipid droplets, detected using
Lipotox red stain, was converted into a mask. This mask was then
duplicated and one copy was dilated twice. The unaltered lipid
mask was then subtracted from the twice dilated lipid mask and
the resulting mask outlined the perimeters of the lipid droplets.
This ‘peri-lipid’ mask was then applied to the HSL confocal
picture and the number of pixels and intensity at each pixel could
be extracted from the histogram for this picture. For the cytosolic
pixel intensity, a mask was generated from the HSL confocal
picture. This mask was then subtracted from the twice dilated lipid
mask generated for the ‘peri-lipid’ analysis. The resulting mask,
termed ‘HSL mask’, included all of the cytosol except that which
was directly around each lipid droplet. This HSL mask was then
applied to the HSL confocal picture and the number of pixels and
intensity at each pixel could be extracted from the histogram for
Reactive Oxygen Species Effect on Lipolysis
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e34904this picture. The index ‘translocation to the lipid droplet’ was then
calculated using the average pixel intensities from the peri-lipid
and cytosol analyses.
(TIF)
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